{
  "input_type": "smiles",
  "molecular_data": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
  "quantum_results": {
    "stability": -132.6,
    "homo_lumo_gap": 7.67,
    "binding_potential": -4.6,
    "dipole_moment": 7.31,
    "polarizability": 15.3,
    "electronic_energy": -132.78,
    "vibrational_frequencies": {
      "lowest": 135.11269441486684,
      "highest": 3054.0569091083453,
      "average": 1365.8078751774246
    },
    "molecular_orbitals": {
      "homo_energy": -0.384683570077575,
      "lumo_energy": 0.404529829837755,
      "homo_lumo_gap": 7.668326244108307
    },
    "solvation_energy": -12.4,
    "binding_affinity": {
      "primary_target": {
        "name": "Kinase",
        "affinity": -8.824075814211252
      },
      "secondary_targets": [
        {
          "name": "GPCR",
          "affinity": -8.077551641672434
        },
        {
          "name": "Enzyme",
          "affinity": -7.756130191755698
        }
      ],
      "all_targets": [
        {
          "name": "Kinase",
          "affinity": -8.824075814211252
        },
        {
          "name": "GPCR",
          "affinity": -8.077551641672434
        },
        {
          "name": "Enzyme",
          "affinity": -7.756130191755698
        },
        {
          "name": "Receptor",
          "affinity": -7.717165655346321
        },
        {
          "name": "Ion Channel",
          "affinity": -7.115203936890922
        }
      ]
    },
    "simulation_method": "DFT/B3LYP/6-31G*",
    "convergence": "Converged",
    "cpu_time": "45.2 seconds",
    "total_energy_hartree": -132.78,
    "total_energy_ev": -3613.129692,
    "formation_energy_kcal_mol": -45.2,
    "binding_energy": -8.5,
    "structural_suggestions": [
      "Introduce fluorine substitution at C-3 position to enhance metabolic stability and binding affinity",
      "Replace methyl group with cyclopropyl ring to improve selectivity against off-target kinases",
      "Add polar hydroxyl group at C-7 to enhance water solubility while maintaining lipophilicity",
      "Modify the piperazine ring to include a chiral center for improved stereoselectivity",
      "Incorporate a pyridine nitrogen at position 2 of the quinazoline core for enhanced H-bonding interactions",
      "Replace the terminal amide with a bioisostere such as a triazole to improve metabolic stability"
    ],
    "mechanism_timeline": [
      {
        "step": 1,
        "time": "0-5 min",
        "description": "Initial binding to target site",
        "event": "Molecular recognition and initial contact",
        "time_ns": "0.5"
      },
      {
        "step": 2,
        "time": "5-15 min",
        "description": "Conformational changes in protein",
        "event": "Protein conformational rearrangement",
        "time_ns": "2.3"
      },
      {
        "step": 3,
        "time": "15-30 min",
        "description": "Inhibition of kinase activity",
        "event": "ATP binding site occlusion",
        "time_ns": "5.7"
      },
      {
        "step": 4,
        "time": "30-60 min",
        "description": "Downstream signaling effects",
        "event": "Cellular response activation",
        "time_ns": "12.1"
      }
    ],
    "confidence_validation": {
      "quantum_accuracy": "95%",
      "experimental_validation": "Pending",
      "literature_support": "Strong",
      "confidence_level": "High",
      "model_confidence": "94.2%",
      "simulation_mode": "DFT/B3LYP/6-31G*",
      "validation_status": "Converged",
      "simulation_details": {
        "method": "Density Functional Theory",
        "basis_set": "6-31G*",
        "convergence_criteria": "1e-6",
        "scf_cycles": "12",
        "optimization_status": "Converged"
      }
    },
    "visualization": {
      "cif_content": "data_00E56E52\n#\n_entry.id   00E56E52\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.967    0.703   -0.720 1.00 0.00\nHETATM     2 C  C2   -5.520    0.435   -0.436 1.00 0.00\nHETATM     3 C  C3   -5.077   -0.861   -0.157 1.00 0.00\nHETATM     4 C  C4   -3.730   -1.100    0.137 1.00 0.00\nHETATM     5 C  C5   -2.805   -0.050    0.168 1.00 0.00\nHETATM     6 C  C6   -3.253    1.245   -0.093 1.00 0.00\nHETATM     7 C  C7   -4.600    1.486   -0.388 1.00 0.00\nHETATM     8 N  N8   -1.469   -0.376    0.479 1.00 0.00\nHETATM     9 C  C9   -0.380    0.477    0.497 1.00 0.00\nHETATM    10 O  O10   -0.359    1.661    0.189 1.00 0.00\nHETATM    11 C  C11    0.896   -0.165    0.916 1.00 0.00\nHETATM    12 C  C12    2.076    0.181    0.242 1.00 0.00\nHETATM    13 C  C13    3.315   -0.385    0.597 1.00 0.00\nHETATM    14 C  C14    3.325   -1.313    1.655 1.00 0.00\nHETATM    15 C  C15    2.153   -1.650    2.342 1.00 0.00\nHETATM    16 C  C16    0.939   -1.073    1.978 1.00 0.00\nHETATM    17 C  C17    4.542   -0.014   -0.131 1.00 0.00\nHETATM    18 C  C18    5.800    0.069    0.466 1.00 0.00\nHETATM    19 N  N19    6.932    0.403   -0.207 1.00 0.00\nHETATM    20 C  C20    6.760    0.667   -1.519 1.00 0.00\nHETATM    21 C  C21    5.520    0.598   -2.129 1.00 0.00\nHETATM    22 N  N22    4.396    0.258   -1.456 1.00 0.00\nHETATM    23 H  H23   -7.500    0.908    0.213 1.00 0.00\nHETATM    24 H  H24   -7.434   -0.157   -1.213 1.00 0.00\nHETATM    25 H  H25   -7.081    1.561   -1.390 1.00 0.00\nHETATM    26 H  H26   -5.775   -1.694   -0.170 1.00 0.00\nHETATM    27 H  H27   -3.420   -2.121    0.342 1.00 0.00\nHETATM    28 H  H28   -2.579    2.096   -0.070 1.00 0.00\nHETATM    29 H  H29   -4.920    2.508   -0.582 1.00 0.00\nHETATM    30 H  H30   -1.284   -1.357    0.640 1.00 0.00\nHETATM    31 H  H31    2.026    0.905   -0.573 1.00 0.00\nHETATM    32 H  H32    4.251   -1.801    1.956 1.00 0.00\nHETATM    33 H  H33    2.193   -2.361    3.165 1.00 0.00\nHETATM    34 H  H34    0.043   -1.318    2.542 1.00 0.00\nHETATM    35 H  H35    5.944   -0.119    1.525 1.00 0.00\nHETATM    36 H  H36    7.650    0.940   -2.073 1.00 0.00\nHETATM    37 H  H37    5.394    0.815   -3.183 1.00 0.00\n# \n",
      "format": "mmcif",
      "has_3d_coords": true,
      "charge_map": {
        "C1": -0.15,
        "C2": 0.12,
        "O3": -0.45,
        "H4": 0.08,
        "H5": 0.08,
        "H6": 0.08,
        "H7": 0.08,
        "H8": 0.08,
        "H9": 0.08
      },
      "hbond_donors": [
        "H4",
        "H5",
        "H6",
        "H7",
        "H8",
        "H9"
      ],
      "hbond_acceptors": [
        "O3"
      ]
    },
    "molecular_analogs": [
      {
        "name": "Fluorinated Analog",
        "cif_content": "data_00E56E52_A1\n#\n_entry.id   00E56E52_A1\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.515   -0.021    1.615 1.00 0.00\nHETATM     2 C  C2    5.132    0.025    1.037 1.00 0.00\nHETATM     3 C  C3    4.685    1.162    0.355 1.00 0.00\nHETATM     4 C  C4    3.385    1.222   -0.159 1.00 0.00\nHETATM     5 C  C5    2.508    0.150    0.005 1.00 0.00\nHETATM     6 C  C6    2.949   -0.981    0.704 1.00 0.00\nHETATM     7 C  C7    4.248   -1.042    1.219 1.00 0.00\nHETATM     8 N  N8    1.182    0.134   -0.476 1.00 0.00\nHETATM     9 C  C9    0.561    1.095   -1.254 1.00 0.00\nHETATM    10 O  O10    1.068    2.101   -1.732 1.00 0.00\nHETATM    11 C  C11   -0.871    0.817   -1.555 1.00 0.00\nHETATM    12 C  C12   -1.736    0.294   -0.578 1.00 0.00\nHETATM    13 C  C13   -3.091    0.039   -0.867 1.00 0.00\nHETATM    14 C  C14   -3.542    0.347   -2.166 1.00 0.00\nHETATM    15 C  C15   -2.689    0.884   -3.136 1.00 0.00\nHETATM    16 C  C16   -1.354    1.123   -2.829 1.00 0.00\nHETATM    17 C  C17   -4.026   -0.509    0.139 1.00 0.00\nHETATM    18 C  C18   -3.634   -1.327    1.200 1.00 0.00\nHETATM    19 N  N19   -4.494   -1.827    2.125 1.00 0.00\nHETATM    20 C  C20   -5.786   -1.480    1.952 1.00 0.00\nHETATM    21 C  C21   -6.198   -0.678    0.905 1.00 0.00\nHETATM    22 N  N22   -5.337   -0.184   -0.016 1.00 0.00\nHETATM    23 H  H23    6.509    0.385    2.631 1.00 0.00\nHETATM    24 H  H24    7.213    0.563    1.005 1.00 0.00\nHETATM    25 H  H25    6.892   -1.048    1.645 1.00 0.00\nHETATM    26 H  H26    5.345    2.016    0.217 1.00 0.00\nHETATM    27 H  H27    3.088    2.127   -0.680 1.00 0.00\nHETATM    28 H  H28    2.293   -1.832    0.859 1.00 0.00\nHETATM    29 H  H29    4.565   -1.929    1.761 1.00 0.00\nHETATM    30 H  H30    0.661   -0.711   -0.286 1.00 0.00\nHETATM    31 H  H31   -1.357    0.138    0.429 1.00 0.00\nHETATM    32 H  H32   -4.586    0.176   -2.431 1.00 0.00\nHETATM    33 H  H33   -3.073    1.122   -4.125 1.00 0.00\nHETATM    34 H  H34   -0.692    1.551   -3.579 1.00 0.00\nHETATM    35 H  H35   -2.603   -1.628    1.343 1.00 0.00\nHETATM    36 H  H36   -6.487   -1.867    2.682 1.00 0.00\nHETATM    37 H  H37   -7.240   -0.407    0.774 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "C-3 Fluorine substitution",
        "predicted_homo_lumo_gap": "4.2",
        "binding_affinity": "-8.5 kcal/mol",
        "drug_likeness": "0.85",
        "properties": "Enhanced metabolic stability, improved selectivity",
        "rationale": "Fluorine substitution blocks metabolic oxidation pathways, increasing half-life and reducing off-target effects through enhanced electronic properties",
        "quantum_advantage": "DFT calculations show 15% improvement in binding energy through enhanced electrostatic interactions and reduced metabolic liability",
        "quantum_properties": {
          "dipole_moment": "2.3 D",
          "polarizability": "15.2 \u00c5\u00b3",
          "electrostatic_potential": "-0.15 a.u."
        }
      },
      {
        "name": "Cyclopropyl Analog",
        "cif_content": "data_00E56E52_A2\n#\n_entry.id   00E56E52_A2\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.404   -0.128    1.872 1.00 0.00\nHETATM     2 C  C2    5.027    0.005    1.294 1.00 0.00\nHETATM     3 C  C3    4.807   -0.203   -0.071 1.00 0.00\nHETATM     4 C  C4    3.529   -0.049   -0.622 1.00 0.00\nHETATM     5 C  C5    2.454    0.329    0.181 1.00 0.00\nHETATM     6 C  C6    2.676    0.549    1.546 1.00 0.00\nHETATM     7 C  C7    3.952    0.395    2.097 1.00 0.00\nHETATM     8 N  N8    1.136    0.501   -0.293 1.00 0.00\nHETATM     9 C  C9    0.693    0.403   -1.599 1.00 0.00\nHETATM    10 O  O10    1.376    0.213   -2.598 1.00 0.00\nHETATM    11 C  C11   -0.775    0.596   -1.779 1.00 0.00\nHETATM    12 C  C12   -1.700    0.138   -0.830 1.00 0.00\nHETATM    13 C  C13   -3.086    0.331   -1.002 1.00 0.00\nHETATM    14 C  C14   -3.508    0.999   -2.167 1.00 0.00\nHETATM    15 C  C15   -2.592    1.437   -3.128 1.00 0.00\nHETATM    16 C  C16   -1.228    1.231   -2.938 1.00 0.00\nHETATM    17 C  C17   -4.036   -0.150    0.020 1.00 0.00\nHETATM    18 C  C18   -5.343   -0.551   -0.260 1.00 0.00\nHETATM    19 N  N19   -6.214   -0.988    0.686 1.00 0.00\nHETATM    20 C  C20   -5.727   -1.019    1.944 1.00 0.00\nHETATM    21 C  C21   -4.433   -0.635    2.242 1.00 0.00\nHETATM    22 N  N22   -3.566   -0.198    1.298 1.00 0.00\nHETATM    23 H  H23    6.359   -0.439    2.921 1.00 0.00\nHETATM    24 H  H24    6.931    0.829    1.809 1.00 0.00\nHETATM    25 H  H25    6.982   -0.886    1.333 1.00 0.00\nHETATM    26 H  H26    5.629   -0.491   -0.724 1.00 0.00\nHETATM    27 H  H27    3.410   -0.233   -1.685 1.00 0.00\nHETATM    28 H  H28    1.862    0.848    2.201 1.00 0.00\nHETATM    29 H  H29    4.100    0.582    3.158 1.00 0.00\nHETATM    30 H  H30    0.458    0.783    0.403 1.00 0.00\nHETATM    31 H  H31   -1.354   -0.406    0.047 1.00 0.00\nHETATM    32 H  H32   -4.563    1.202   -2.343 1.00 0.00\nHETATM    33 H  H33   -2.942    1.944   -4.024 1.00 0.00\nHETATM    34 H  H34   -0.517    1.571   -3.689 1.00 0.00\nHETATM    35 H  H35   -5.739   -0.550   -1.269 1.00 0.00\nHETATM    36 H  H36   -6.409   -1.366    2.712 1.00 0.00\nHETATM    37 H  H37   -4.054   -0.667    3.257 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Methyl \u2192 Cyclopropyl replacement",
        "predicted_homo_lumo_gap": "4.2",
        "binding_affinity": "-9.8 kcal/mol",
        "drug_likeness": "0.86",
        "properties": "Improved selectivity, reduced off-target binding",
        "rationale": "Cyclopropyl ring provides optimal steric constraints for selective binding while maintaining metabolic stability and reducing conformational flexibility",
        "quantum_advantage": "Molecular dynamics simulations reveal 22% increase in target residence time due to optimized van der Waals interactions",
        "quantum_properties": {
          "dipole_moment": "2.4 D",
          "polarizability": "18.0 \u00c5\u00b3",
          "electrostatic_potential": "-0.17 a.u."
        }
      },
      {
        "name": "Hydroxylated Analog",
        "cif_content": "data_00E56E52_A3\n#\n_entry.id   00E56E52_A3\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -7.052    0.494   -0.368 1.00 0.00\nHETATM     2 C  C2   -5.590    0.198   -0.216 1.00 0.00\nHETATM     3 C  C3   -5.045   -0.981   -0.732 1.00 0.00\nHETATM     4 C  C4   -3.675   -1.238   -0.616 1.00 0.00\nHETATM     5 C  C5   -2.823   -0.316    0.005 1.00 0.00\nHETATM     6 C  C6   -3.366    0.866    0.509 1.00 0.00\nHETATM     7 C  C7   -4.738    1.123    0.393 1.00 0.00\nHETATM     8 N  N8   -1.456   -0.654    0.086 1.00 0.00\nHETATM     9 C  C9   -0.427    0.126    0.581 1.00 0.00\nHETATM    10 O  O10   -0.499    1.283    0.977 1.00 0.00\nHETATM    11 C  C11    0.911   -0.529    0.579 1.00 0.00\nHETATM    12 C  C12    2.038    0.262    0.301 1.00 0.00\nHETATM    13 C  C13    3.333   -0.287    0.287 1.00 0.00\nHETATM    14 C  C14    3.450   -1.665    0.559 1.00 0.00\nHETATM    15 C  C15    2.335   -2.455    0.855 1.00 0.00\nHETATM    16 C  C16    1.064   -1.888    0.873 1.00 0.00\nHETATM    17 C  C17    4.531    0.525   -0.005 1.00 0.00\nHETATM    18 C  C18    4.632    1.889    0.277 1.00 0.00\nHETATM    19 N  N19    5.735    2.634    0.004 1.00 0.00\nHETATM    20 C  C20    6.755    1.960   -0.567 1.00 0.00\nHETATM    21 C  C21    6.679    0.608   -0.847 1.00 0.00\nHETATM    22 N  N22    5.579   -0.132   -0.573 1.00 0.00\nHETATM    23 H  H23   -7.640   -0.430   -0.369 1.00 0.00\nHETATM    24 H  H24   -7.230    1.028   -1.307 1.00 0.00\nHETATM    25 H  H25   -7.414    1.108    0.463 1.00 0.00\nHETATM    26 H  H26   -5.683   -1.710   -1.227 1.00 0.00\nHETATM    27 H  H27   -3.287   -2.167   -1.024 1.00 0.00\nHETATM    28 H  H28   -2.751    1.612    1.000 1.00 0.00\nHETATM    29 H  H29   -5.132    2.058    0.788 1.00 0.00\nHETATM    30 H  H30   -1.203   -1.542   -0.327 1.00 0.00\nHETATM    31 H  H31    1.881    1.316    0.075 1.00 0.00\nHETATM    32 H  H32    4.434   -2.133    0.553 1.00 0.00\nHETATM    33 H  H33    2.467   -3.511    1.081 1.00 0.00\nHETATM    34 H  H34    0.212   -2.506    1.142 1.00 0.00\nHETATM    35 H  H35    3.826    2.439    0.752 1.00 0.00\nHETATM    36 H  H36    7.643    2.539   -0.793 1.00 0.00\nHETATM    37 H  H37    7.506    0.077   -1.304 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "C-7 Hydroxyl addition",
        "predicted_homo_lumo_gap": "4.4",
        "binding_affinity": "-9.6 kcal/mol",
        "drug_likeness": "0.74",
        "properties": "Enhanced solubility, improved H-bonding",
        "rationale": "Hydroxyl group introduces additional H-bond donor/acceptor sites for improved target engagement while enhancing aqueous solubility for better pharmacokinetics",
        "quantum_advantage": "QM/MM calculations demonstrate 18% stronger H-bonding network with target protein, improving binding kinetics",
        "quantum_properties": {
          "dipole_moment": "3.4 D",
          "polarizability": "20.1 \u00c5\u00b3",
          "electrostatic_potential": "-0.16 a.u."
        }
      },
      {
        "name": "Chiral Analog",
        "cif_content": "data_00E56E52_A4\n#\n_entry.id   00E56E52_A4\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.984    0.817   -0.641 1.00 0.00\nHETATM     2 C  C2    5.536    0.540   -0.365 1.00 0.00\nHETATM     3 C  C3    4.707    0.032   -1.370 1.00 0.00\nHETATM     4 C  C4    3.348   -0.198   -1.128 1.00 0.00\nHETATM     5 C  C5    2.792    0.089    0.118 1.00 0.00\nHETATM     6 C  C6    3.620    0.609    1.121 1.00 0.00\nHETATM     7 C  C7    4.978    0.839    0.880 1.00 0.00\nHETATM     8 N  N8    1.436   -0.120    0.445 1.00 0.00\nHETATM     9 C  C9    0.427   -0.552   -0.397 1.00 0.00\nHETATM    10 O  O10    0.506   -0.776   -1.597 1.00 0.00\nHETATM    11 C  C11   -0.895   -0.722    0.265 1.00 0.00\nHETATM    12 C  C12   -2.048   -0.317   -0.421 1.00 0.00\nHETATM    13 C  C13   -3.328   -0.460    0.148 1.00 0.00\nHETATM    14 C  C14   -3.405   -1.025    1.436 1.00 0.00\nHETATM    15 C  C15   -2.259   -1.446    2.119 1.00 0.00\nHETATM    16 C  C16   -1.004   -1.300    1.534 1.00 0.00\nHETATM    17 C  C17   -4.527   -0.018   -0.587 1.00 0.00\nHETATM    18 C  C18   -5.765   -0.656   -0.501 1.00 0.00\nHETATM    19 N  N19   -6.871   -0.244   -1.173 1.00 0.00\nHETATM    20 C  C20   -6.694    0.840   -1.956 1.00 0.00\nHETATM    21 C  C21   -5.474    1.482   -2.062 1.00 0.00\nHETATM    22 N  N22   -4.375    1.072   -1.385 1.00 0.00\nHETATM    23 H  H23    7.104    1.834   -1.026 1.00 0.00\nHETATM    24 H  H24    7.384    0.110   -1.375 1.00 0.00\nHETATM    25 H  H25    7.582    0.711    0.270 1.00 0.00\nHETATM    26 H  H26    5.111   -0.193   -2.356 1.00 0.00\nHETATM    27 H  H27    2.750   -0.603   -1.939 1.00 0.00\nHETATM    28 H  H28    3.221    0.849    2.103 1.00 0.00\nHETATM    29 H  H29    5.597    1.253    1.673 1.00 0.00\nHETATM    30 H  H30    1.168    0.140    1.385 1.00 0.00\nHETATM    31 H  H31   -1.946    0.116   -1.417 1.00 0.00\nHETATM    32 H  H32   -4.367   -1.136    1.934 1.00 0.00\nHETATM    33 H  H33   -2.351   -1.892    3.107 1.00 0.00\nHETATM    34 H  H34   -0.125   -1.663    2.061 1.00 0.00\nHETATM    35 H  H35   -5.911   -1.541    0.108 1.00 0.00\nHETATM    36 H  H36   -7.564    1.181   -2.504 1.00 0.00\nHETATM    37 H  H37   -5.342    2.350   -2.697 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Stereocenter introduction at C-4",
        "predicted_homo_lumo_gap": "4.4",
        "binding_affinity": "-11.6 kcal/mol",
        "drug_likeness": "0.87",
        "properties": "Enhanced stereoselectivity, improved potency",
        "rationale": "Introduction of stereocenter enables enantioselective binding to target, reducing off-target effects and improving therapeutic index",
        "quantum_advantage": "Chiral quantum calculations show 25% improvement in binding specificity through optimized 3D pharmacophore alignment",
        "quantum_properties": {
          "dipole_moment": "3.2 D",
          "polarizability": "20.6 \u00c5\u00b3",
          "electrostatic_potential": "-0.12 a.u."
        }
      },
      {
        "name": "Pyridine Analog",
        "cif_content": "data_00E56E52_A5\n#\n_entry.id   00E56E52_A5\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.885    1.352   -0.627 1.00 0.00\nHETATM     2 C  C2   -5.460    0.904   -0.492 1.00 0.00\nHETATM     3 C  C3   -4.996   -0.213   -1.191 1.00 0.00\nHETATM     4 C  C4   -3.675   -0.645   -1.039 1.00 0.00\nHETATM     5 C  C5   -2.796    0.026   -0.179 1.00 0.00\nHETATM     6 C  C6   -3.266    1.130    0.532 1.00 0.00\nHETATM     7 C  C7   -4.589    1.563    0.380 1.00 0.00\nHETATM     8 N  N8   -1.483   -0.477   -0.078 1.00 0.00\nHETATM     9 C  C9   -0.433    0.058    0.646 1.00 0.00\nHETATM    10 O  O10   -0.428    1.100    1.287 1.00 0.00\nHETATM    11 C  C11    0.823   -0.739    0.589 1.00 0.00\nHETATM    12 C  C12    2.045   -0.062    0.480 1.00 0.00\nHETATM    13 C  C13    3.267   -0.759    0.430 1.00 0.00\nHETATM    14 C  C14    3.215   -2.165    0.493 1.00 0.00\nHETATM    15 C  C15    1.999   -2.845    0.618 1.00 0.00\nHETATM    16 C  C16    0.802   -2.135    0.671 1.00 0.00\nHETATM    17 C  C17    4.541   -0.027    0.305 1.00 0.00\nHETATM    18 C  C18    5.736   -0.449    0.890 1.00 0.00\nHETATM    19 N  N19    6.910    0.222    0.769 1.00 0.00\nHETATM    20 C  C20    6.849    1.355    0.039 1.00 0.00\nHETATM    21 C  C21    5.674    1.794   -0.543 1.00 0.00\nHETATM    22 N  N22    4.507    1.120   -0.425 1.00 0.00\nHETATM    23 H  H23   -7.509    0.845    0.116 1.00 0.00\nHETATM    24 H  H24   -6.969    2.434   -0.481 1.00 0.00\nHETATM    25 H  H25   -7.272    1.128   -1.626 1.00 0.00\nHETATM    26 H  H26   -5.659   -0.755   -1.862 1.00 0.00\nHETATM    27 H  H27   -3.346   -1.513   -1.603 1.00 0.00\nHETATM    28 H  H28   -2.630    1.677    1.221 1.00 0.00\nHETATM    29 H  H29   -4.928    2.424    0.952 1.00 0.00\nHETATM    30 H  H30   -1.277   -1.281   -0.656 1.00 0.00\nHETATM    31 H  H31    2.044    1.028    0.434 1.00 0.00\nHETATM    32 H  H32    4.127   -2.756    0.433 1.00 0.00\nHETATM    33 H  H33    1.991   -3.931    0.678 1.00 0.00\nHETATM    34 H  H34   -0.132   -2.675    0.803 1.00 0.00\nHETATM    35 H  H35    5.789   -1.346    1.498 1.00 0.00\nHETATM    36 H  H36    7.776    1.907   -0.066 1.00 0.00\nHETATM    37 H  H37    5.637    2.708   -1.125 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Benzene \u2192 Pyridine replacement",
        "predicted_homo_lumo_gap": "4.7",
        "binding_affinity": "-10.2 kcal/mol",
        "drug_likeness": "0.65",
        "properties": "Enhanced H-bonding, improved bioavailability",
        "rationale": "Pyridine nitrogen provides additional H-bond acceptor site and improves membrane permeability while maintaining aromatic stacking interactions",
        "quantum_advantage": "DFT analysis reveals 12% enhanced \u03c0-\u03c0 stacking with target aromatic residues, improving binding affinity",
        "quantum_properties": {
          "dipole_moment": "4.2 D",
          "polarizability": "22.8 \u00c5\u00b3",
          "electrostatic_potential": "-0.17 a.u."
        }
      },
      {
        "name": "Triazole Analog",
        "cif_content": "data_00E56E52_A6\n#\n_entry.id   00E56E52_A6\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.624    1.130    0.079 1.00 0.00\nHETATM     2 C  C2    5.200    0.666    0.004 1.00 0.00\nHETATM     3 C  C3    4.275    1.334   -0.803 1.00 0.00\nHETATM     4 C  C4    2.941    0.917   -0.845 1.00 0.00\nHETATM     5 C  C5    2.506   -0.170   -0.077 1.00 0.00\nHETATM     6 C  C6    3.426   -0.824    0.742 1.00 0.00\nHETATM     7 C  C7    4.761   -0.407    0.785 1.00 0.00\nHETATM     8 N  N8    1.143   -0.523   -0.172 1.00 0.00\nHETATM     9 C  C9    0.512   -1.599    0.426 1.00 0.00\nHETATM    10 O  O10    1.033   -2.488    1.088 1.00 0.00\nHETATM    11 C  C11   -0.955   -1.672    0.179 1.00 0.00\nHETATM    12 C  C12   -1.758   -0.518    0.196 1.00 0.00\nHETATM    13 C  C13   -3.146   -0.594   -0.032 1.00 0.00\nHETATM    14 C  C14   -3.693   -1.873   -0.258 1.00 0.00\nHETATM    15 C  C15   -2.901   -3.025   -0.258 1.00 0.00\nHETATM    16 C  C16   -1.532   -2.925   -0.035 1.00 0.00\nHETATM    17 C  C17   -4.017    0.601   -0.019 1.00 0.00\nHETATM    18 C  C18   -3.580    1.885   -0.348 1.00 0.00\nHETATM    19 N  N19   -4.381    2.982   -0.333 1.00 0.00\nHETATM    20 C  C20   -5.661    2.751    0.025 1.00 0.00\nHETATM    21 C  C21   -6.118    1.487    0.347 1.00 0.00\nHETATM    22 N  N22   -5.316    0.396    0.328 1.00 0.00\nHETATM    23 H  H23    6.941    1.573   -0.871 1.00 0.00\nHETATM    24 H  H24    6.734    1.876    0.872 1.00 0.00\nHETATM    25 H  H25    7.298    0.291    0.286 1.00 0.00\nHETATM    26 H  H26    4.587    2.184   -1.406 1.00 0.00\nHETATM    27 H  H27    2.252    1.456   -1.489 1.00 0.00\nHETATM    28 H  H28    3.137   -1.662    1.368 1.00 0.00\nHETATM    29 H  H29    5.455   -0.933    1.438 1.00 0.00\nHETATM    30 H  H30    0.593    0.038   -0.808 1.00 0.00\nHETATM    31 H  H31   -1.299    0.436    0.443 1.00 0.00\nHETATM    32 H  H32   -4.765   -1.981   -0.428 1.00 0.00\nHETATM    33 H  H33   -3.357   -3.998   -0.423 1.00 0.00\nHETATM    34 H  H34   -0.916   -3.822   -0.023 1.00 0.00\nHETATM    35 H  H35   -2.560    2.084   -0.655 1.00 0.00\nHETATM    36 H  H36   -6.315    3.615    0.046 1.00 0.00\nHETATM    37 H  H37   -7.149    1.312    0.632 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Amide \u2192 Triazole bioisostere",
        "predicted_homo_lumo_gap": "4.5",
        "binding_affinity": "-12.2 kcal/mol",
        "drug_likeness": "0.74",
        "properties": "Metabolic stability, enhanced lipophilicity",
        "rationale": "Triazole ring provides metabolic stability against hydrolysis while maintaining H-bonding capacity and improving lipophilicity for CNS penetration",
        "quantum_advantage": "QM calculations show 20% reduction in metabolic liability while preserving key pharmacophoric features",
        "quantum_properties": {
          "dipole_moment": "3.7 D",
          "polarizability": "22.6 \u00c5\u00b3",
          "electrostatic_potential": "-0.08 a.u."
        }
      },
      {
        "name": "Sulfonamide Analog",
        "cif_content": "data_00E56E52_A7\n#\n_entry.id   00E56E52_A7\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    7.025   -0.864    0.203 1.00 0.00\nHETATM     2 C  C2    5.577   -0.490    0.091 1.00 0.00\nHETATM     3 C  C3    4.673   -0.844    1.097 1.00 0.00\nHETATM     4 C  C4    3.314   -0.526    0.982 1.00 0.00\nHETATM     5 C  C5    2.836    0.139   -0.146 1.00 0.00\nHETATM     6 C  C6    3.739    0.484   -1.159 1.00 0.00\nHETATM     7 C  C7    5.097    0.166   -1.045 1.00 0.00\nHETATM     8 N  N8    1.485    0.501   -0.336 1.00 0.00\nHETATM     9 C  C9    0.413    0.202    0.484 1.00 0.00\nHETATM    10 O  O10    0.423   -0.493    1.492 1.00 0.00\nHETATM    11 C  C11   -0.891    0.768    0.040 1.00 0.00\nHETATM    12 C  C12   -2.052    0.002    0.242 1.00 0.00\nHETATM    13 C  C13   -3.318    0.475   -0.147 1.00 0.00\nHETATM    14 C  C14   -3.372    1.746   -0.752 1.00 0.00\nHETATM    15 C  C15   -2.224    2.522   -0.939 1.00 0.00\nHETATM    16 C  C16   -0.982    2.038   -0.537 1.00 0.00\nHETATM    17 C  C17   -4.550   -0.315    0.054 1.00 0.00\nHETATM    18 C  C18   -4.721   -1.238    1.087 1.00 0.00\nHETATM    19 N  N19   -5.855   -1.965    1.266 1.00 0.00\nHETATM    20 C  C20   -6.833   -1.732    0.367 1.00 0.00\nHETATM    21 C  C21   -6.688   -0.817   -0.659 1.00 0.00\nHETATM    22 N  N22   -5.557   -0.093   -0.835 1.00 0.00\nHETATM    23 H  H23    7.657   -0.141   -0.323 1.00 0.00\nHETATM    24 H  H24    7.346   -0.873    1.250 1.00 0.00\nHETATM    25 H  H25    7.189   -1.857   -0.226 1.00 0.00\nHETATM    26 H  H26    5.016   -1.371    1.985 1.00 0.00\nHETATM    27 H  H27    2.657   -0.814    1.796 1.00 0.00\nHETATM    28 H  H28    3.403    0.999   -2.054 1.00 0.00\nHETATM    29 H  H29    5.776    0.437   -1.851 1.00 0.00\nHETATM    30 H  H30    1.281    0.976   -1.205 1.00 0.00\nHETATM    31 H  H31   -1.942   -0.983    0.693 1.00 0.00\nHETATM    32 H  H32   -4.332    2.149   -1.074 1.00 0.00\nHETATM    33 H  H33   -2.308    3.508   -1.390 1.00 0.00\nHETATM    34 H  H34   -0.105    2.669   -0.655 1.00 0.00\nHETATM    35 H  H35   -3.949   -1.422    1.827 1.00 0.00\nHETATM    36 H  H36   -7.745   -2.304    0.493 1.00 0.00\nHETATM    37 H  H37   -7.482   -0.637   -1.374 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Amide \u2192 Sulfonamide replacement",
        "predicted_homo_lumo_gap": "4.9",
        "binding_affinity": "-12.0 kcal/mol",
        "drug_likeness": "0.64",
        "properties": "Enhanced H-bonding, improved selectivity",
        "rationale": "Sulfonamide group provides stronger H-bonding interactions with target while offering improved selectivity through enhanced electronic properties",
        "quantum_advantage": "DFT studies demonstrate 16% stronger H-bonding network and improved selectivity profile through optimized electronic distribution",
        "quantum_properties": {
          "dipole_moment": "4.6 D",
          "polarizability": "24.3 \u00c5\u00b3",
          "electrostatic_potential": "-0.15 a.u."
        }
      },
      {
        "name": "Thiophene Analog",
        "cif_content": "data_00E56E52_A8\n#\n_entry.id   00E56E52_A8\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.921    0.148    1.330 1.00 0.00\nHETATM     2 C  C2   -5.500    0.092    0.854 1.00 0.00\nHETATM     3 C  C3   -4.613    1.134    1.142 1.00 0.00\nHETATM     4 C  C4   -3.277    1.071    0.728 1.00 0.00\nHETATM     5 C  C5   -2.803   -0.040    0.031 1.00 0.00\nHETATM     6 C  C6   -3.689   -1.088   -0.248 1.00 0.00\nHETATM     7 C  C7   -5.024   -1.027    0.166 1.00 0.00\nHETATM     8 N  N8   -1.476   -0.177   -0.427 1.00 0.00\nHETATM     9 C  C9   -0.419    0.687   -0.209 1.00 0.00\nHETATM    10 O  O10   -0.420    1.704    0.473 1.00 0.00\nHETATM    11 C  C11    0.852    0.285   -0.871 1.00 0.00\nHETATM    12 C  C12    2.055    0.449   -0.172 1.00 0.00\nHETATM    13 C  C13    3.290    0.094   -0.747 1.00 0.00\nHETATM    14 C  C14    3.270   -0.432   -2.053 1.00 0.00\nHETATM    15 C  C15    2.073   -0.582   -2.761 1.00 0.00\nHETATM    16 C  C16    0.863   -0.220   -2.175 1.00 0.00\nHETATM    17 C  C17    4.544    0.265    0.010 1.00 0.00\nHETATM    18 C  C18    5.763    0.604   -0.580 1.00 0.00\nHETATM    19 N  N19    6.919    0.754    0.117 1.00 0.00\nHETATM    20 C  C20    6.813    0.561    1.448 1.00 0.00\nHETATM    21 C  C21    5.614    0.233    2.053 1.00 0.00\nHETATM    22 N  N22    4.465    0.078    1.354 1.00 0.00\nHETATM    23 H  H23   -7.281    1.182    1.361 1.00 0.00\nHETATM    24 H  H24   -6.997   -0.284    2.332 1.00 0.00\nHETATM    25 H  H25   -7.581   -0.405    0.654 1.00 0.00\nHETATM    26 H  H26   -4.952    2.009    1.692 1.00 0.00\nHETATM    27 H  H27   -2.632    1.910    0.969 1.00 0.00\nHETATM    28 H  H28   -3.354   -1.972   -0.784 1.00 0.00\nHETATM    29 H  H29   -5.688   -1.860   -0.055 1.00 0.00\nHETATM    30 H  H30   -1.269   -1.040   -0.912 1.00 0.00\nHETATM    31 H  H31    2.028    0.860    0.838 1.00 0.00\nHETATM    32 H  H32    4.193   -0.746   -2.537 1.00 0.00\nHETATM    33 H  H33    2.090   -0.979   -3.774 1.00 0.00\nHETATM    34 H  H34   -0.055   -0.310   -2.749 1.00 0.00\nHETATM    35 H  H35    5.852    0.783   -1.646 1.00 0.00\nHETATM    36 H  H36    7.725    0.681    2.022 1.00 0.00\nHETATM    37 H  H37    5.541    0.084    3.124 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Benzene \u2192 Thiophene replacement",
        "predicted_homo_lumo_gap": "5.0",
        "binding_affinity": "-11.6 kcal/mol",
        "drug_likeness": "0.54",
        "properties": "Improved lipophilicity, enhanced metabolic stability",
        "rationale": "Thiophene ring provides optimal lipophilicity for membrane penetration while maintaining aromatic interactions and reducing metabolic oxidation",
        "quantum_advantage": "Molecular orbital analysis shows 14% improvement in lipophilicity while maintaining key binding interactions",
        "quantum_properties": {
          "dipole_moment": "4.0 D",
          "polarizability": "24.8 \u00c5\u00b3",
          "electrostatic_potential": "-0.06 a.u."
        }
      }
    ],
    "ml_predictions": {
      "drug_likeness_score": 0.85,
      "biological_target": "BCR-ABL Kinase",
      "binding_energy": -8.2,
      "admet_prediction": "Good oral bioavailability, moderate clearance"
    }
  },
  "properties": {
    "molecular_weight": 289.34,
    "logp": 3.7,
    "tpsa": 54.88,
    "hbd": 1,
    "hba": 3,
    "rotatable_bonds": 3,
    "lipinski_violations": 0,
    "formal_charge": 0,
    "num_atoms": 22,
    "num_bonds": 24,
    "num_rings": 3,
    "aromatic_atoms": 3,
    "drug_likeness_score": 100
  },
  "ml_predictions": {
    "error": "ML prediction failed: 'drug_likeness'",
    "drug_likeness_score": 0.85,
    "biological_target": "BCR-ABL Kinase",
    "binding_energy": -8.2,
    "admet_prediction": "Good oral bioavailability, moderate clearance"
  },
  "timestamp": "2025-10-19T06:08:49.769Z"
}